Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Hualan Biological Engineering Inc.
  6. News
  7. Sector news
    002007   CNE000001JN8

HUALAN BIOLOGICAL ENGINEERING INC.

(002007)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
01/21Gilead Gets FDA Approval for Remdesivir for Some Non-Hospitalized Patients
DJ
01/21Gilead Sciences, Inc. Announces FDA Approves Veklury« for the Treatment of Non-Hospital..
CI
01/21UBS Adjusts BioNTech SE Price Target to $170 From $300, Maintains Neutral Rating
MT
01/21GSK, Vir ramping up U.S. output of COVID antibody drug
RE
01/21Pfizer-BioNTech's COVID-19 Vaccine Gets WHO Backing for Kids 5 to 11 Years Old
MT
01/21European ADRs Move Lower in Friday Trading
MT
01/21Japan OKs Pfizer/BioNTech's COVID-19 Vaccine For Children
MT
01/21Japan Clears Use of Pfizer's COVID-19 Vaccine on Children
MT
01/20ANALYST RECOMMENDATIONS : Activision Blizzard, AMD, Bumble, Etsy, Ford...
01/20BMO Capital Lifts Vertex Pharmaceuticals to Outperform From Market Perform, Price Targe..
MT
01/19SiteOne Therapeutics Announces Collaboration and License Agreement with Vertex Pharmace..
CI
01/19Regeneron Says US FDA Accepts for Review its Supplemental BLA for Libtayo in Combinatio..
MT
01/19Regeneron Says FDA to Review Libtayo/Chemotherapy Combo in First-Line NSCLC Treatment
DJ
01/19FDA Accepts for Review Libtayo« (cemiplimab-rwlc) in Combination with Chemotherapy for ..
CI
01/19ANALYST RECOMMENDATIONS : Activision Blizzard, Chevron, Exxon Mobil, Gilead, Goldman Sachs..
01/19BIONTECH : Goldman Sachs sticks Neutral
MD
01/19Sanofi, Regeneron Say Dupixent Significantly Reduces Itching in Prurigo Nodularis Patie..
MT
01/19Sanofi-Regeneron's Dermatitis Drug Lowers Itch, Skin Lesions In Late-Stage Trial
MT
01/18Fourth Pfizer-BioNTech COVID-19 Shot Fails to Prevent Omicron Infection in Israeli Stud..
MT
01/18Gilead says counterfeit HIV drugs ended up with patients
RE
01/18Morgan Stanley Lowers Price Target for Gilead Sciences to $72 From $74, Maintains Equal..
MT
01/18Gilead says counterfeiting network sold $250 mln worth of its HIV drugs
RE
01/18Morgan Stanley Adjusts Regeneron Pharmaceuticals Price Target to $585 From $617, Mainta..
MT
01/18Morgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
01/18European ADRs Move Lower in Tuesday Trading
MT
01/18European Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/18WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/14Gilead withdraws use of Zydelig to treat two types of cancer
RE
01/13WHO recommends Eli Lilly, GSK-Vir's drugs, widening COVID-19 treatment pool
RE
01/13European ADRs Move Higher in Thursday Trading
MT
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/13Countryside Slumps 17% as CEO Steps Down Amid Deal with Activist Investor
MT
01/13Countryside Properties CEO Steps Down; Chair Named As Interim Successor
MT
01/12Pfizer's Pneumonia Jab, COVID-19 Booster Shot Safe for Coadministration in Late-Stage S..
MT
01/12BIONTECH : Goldman Sachs reaffirms its Neutral rating
MD
01/12Pfizer Says Pneumococcal Vaccine Combined with COVID-19 Shot Effective in Adults Above ..
MT
01/12Pfizer Reports Positive Results From Study Co-Administering Vaccines for Covid-19, Pneu..
DJ
01/12South African Institute To Study Effects Of Pfizer, BioNTech, Johnson & Johnson Booster..
MT
01/11U.S. FDA amends J&J vaccine fact sheet to include rare bleeding risk
RE
01/11BioNTech, InstaDeep Develop System to Predict High-Risk COVID-19 Variants
MT
01/11European ADRs Nudge Lower in Tuesday Trading
MT
01/11BioNTech Sees COVID-19 Vaccine Revenue of Up to 17 Billion Euros in 2021, 2022
MT
01/11BioNTech Says 2022 Vaccine Revenue Expected To Hit $19 Billion
MT
01/11BioNTech, InstaDeep Develop Early Warning System To Flag High-Risk COVID-19 Variants
MT
01/11BioNTech SE and InstaDeep Ltd Developed and Successfully Tested Early Warning System to..
CI
01/11Vertex's Cystic Fibrosis Combo Gets Extended EU Nod For Treating Children
MT
01/11Vertex Secures European Commission's Approval for Kaftrio With Ivacaftor as Treatment f..
MT
01/11Vertex Pharmaceuticals Incorporated announces European Commission Approves KAFTRIO« (iv..
CI
01/10Gilead, Merck & Co. to Evaluate Lung Cancer Combo Therapy in Two Clinical Studies
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on HUALAN BIOLOGICAL ENGINEERING INC.
03/29/22